quinazolines has been researched along with Obesity in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 10 (47.62) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, Y; Gu, P; Hui, X; Lin, S; Liu, X; Loomes, K; Mao, L; Nie, T; Tang, S; Wu, D; Xu, Y; Zhang, Y; Zhao, S; Zhao, X | 1 |
| Ahmad, H; Dogra, S; Dwivedi, AK; Jaiswal, S; Kumar, A; Lal, J; Pasam, VR; Rashid, M; Shukla, M; Siddiqi, MI; Singh, K; Singh, M; Singh, SK; Sona, C; Thakur, RK; Tripathi, RP; Umrao, D; Wahajuddin, M; Yadav, A; Yadav, PN | 1 |
| Hansen, G; Hansen, HH; Jelsing, J; Klein, T; Mark, M; Paulsen, S; Vrang, N | 1 |
| Kobayashi, Y | 1 |
| Fang, Q; Li, W; Li, X; Liang, G; Lin, F; Wang, L; Wang, Y; Zhang, Y; Zheng, C; Zhong, P; Zou, C | 1 |
| Beck-Nielsen, H; Byrjalsen, I; Christiansen, C; Henriksen, K; Karsdal, MA; Larsen, LK; Madsen, AN; Nielsen, RH | 1 |
| Chae, S; Han, MD; Kim, SJ; Lee, S; Lee, SJ; Mar, W; Nam, KW | 1 |
| Bak, EJ; Cha, JH; Kim, JM; Park, HG; Yoo, YJ | 1 |
| Akanuma, M; Fujiya, M; Hiranaka, N; Ieko, M; Kanazawa, K; Kohgo, Y; Naito, S; Oka, K; Suzuki, T; Takahashi, N; Yoshida, M; Yoshizaki, T; Yui, T | 1 |
| Cheetham, S; Ittrich, C; Kassubek, J; Klein, T; Mark, M; Mayoux, E; Mueller, HP; Niessen, HG; Stiller, D | 1 |
| Blüher, M; Kern, M; Klein, T; Klöting, N; Mark, M; Niessen, HG; Stiller, D; Thomas, L | 1 |
| Birmingham, GD; Cheetham, SC; Dickinson, K; Grempler, R; Headland, KR; Hocher, B; Klein, T; Mark, M; Rowley, HL; Vickers, SP | 1 |
| Darlöf, E; Darsalia, V; Klein, T; Nyström, T; Olverling, A; Ortsäter, H; Patrone, C; Sjöholm, Å; Wolbert, P | 1 |
| Ihara, S; Kawana, M; Sakai, R; Shimamoto, K; Watanabe, H | 1 |
| Kobayashi, Y; Kontani, Y; Mori, N; Sato, Y; Wang, T; Wang, Y; Yamashita, H | 1 |
| Chen, Z; Christofi, FL; Cooke, HJ; Grants, I; Melvin, WS; Mikami, DJ; Needleman, BJ; Wang, Y; Wunderlich, JE; Yu, JG | 1 |
| Bönner, G; Chrosch, R; Schmieder, R; Weidinger, G | 1 |
| Rabl, W; Standl, E; Stemplinger, J; Stiegler, H; Weichenhain, B; Ziegler, AG | 1 |
| Hoshikuma, K; Kamiya, T; Kizaki, M; Kobayashi, Y; Nakano, Y; Yokoo, Y | 1 |
| Asakura, Y; Harano, Y; Hirose, J; Kageyama, A; Omae, T; Sato, A; Suzuki, M | 1 |
| Fujioka, S; Kawamoto, T; Keno, Y; Kobatake, T; Matsuzawa, Y; Tarui, S; Tokunaga, K; Watanabe, Y; Yoshida, H | 1 |
2 trial(s) available for quinazolines and Obesity
| Article | Year |
|---|---|
An alpha1-receptor blocker reduces plasma leptin levels in hypertensive patients with obesity and hyperleptinemia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure; Body Mass Index; Delayed-Action Preparations; Fatty Acids, Nonesterified; Female; Heart Rate; Humans; Hypertension; Insulin Resistance; Leptin; Male; Middle Aged; Obesity; Quinazolines; Receptors, Leptin; Treatment Outcome | 2006 |
Effect of bunazosin and atenolol on glucose metabolism in obese, nondiabetic patients with primary hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Blood Glucose; Double-Blind Method; Female; Glucose; Glucose Tolerance Test; Humans; Hypertension; Insulin; Lipids; Male; Middle Aged; Obesity; Quinazolines | 1997 |
19 other study(ies) available for quinazolines and Obesity
| Article | Year |
|---|---|
The natural compound rutaecarpine promotes white adipocyte browning through activation of the AMPK-PRDM16 axis.
Topics: Adipocytes, Beige; Adipocytes, White; AMP-Activated Protein Kinases; Animals; Biological Products; Disease Models, Animal; DNA-Binding Proteins; Drug Evaluation, Preclinical; In Vitro Techniques; Indole Alkaloids; Male; Mice; Mice, Transgenic; Models, Biological; Obesity; Oxygen Consumption; Quinazolines; Signal Transduction; Thermogenesis; Transcription Factors | 2021 |
Novel Tetrahydroquinazolinamines as Selective Histamine 3 Receptor Antagonists for the Treatment of Obesity.
Topics: Animals; Anti-Obesity Agents; Blood Glucose; Diet, High-Fat; HEK293 Cells; Histamine H3 Antagonists; Humans; Male; Mice, Inbred C57BL; Molecular Structure; Obesity; Proto-Oncogene Proteins c-fos; Quinazolines; Receptors, Histamine H3; Stereoisomerism; Structure-Activity Relationship; Weight Loss | 2019 |
The DPP-IV inhibitor linagliptin and GLP-1 induce synergistic effects on body weight loss and appetite suppression in the diet-induced obese rat.
Topics: Animals; Appetite Depressants; Body Weight; Diet, High-Fat; Dietary Sucrose; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Drug Therapy, Combination; Glucagon-Like Peptide 1; Linagliptin; Male; Obesity; Purines; Quinazolines; Rats; Rats, Sprague-Dawley; Weight Loss | 2014 |
[Effects of evodiamine, a major alkaloid of Goshuyu (Evodia Fruits), on TRPV1].
Topics: Body Temperature; Evodia; Fruit; Humans; Obesity; Pain Management; Quinazolines; TRPV Cation Channels | 2015 |
EGFR mediates hyperlipidemia-induced renal injury via regulating inflammation and oxidative stress: the detrimental role and mechanism of EGFR activation.
Topics: Animals; Cell Line; CSK Tyrosine-Protein Kinase; Enzyme Inhibitors; ErbB Receptors; Hyperlipidemias; Immunoblotting; Inflammation; Kidney; Male; Mice, Inbred C57BL; Mice, Knockout; Obesity; Oxidative Stress; Phosphorylation; Quinazolines; Rats; RNA Interference; src-Family Kinases; Tyrphostins | 2016 |
A comparison of glycemic control, water retention, and musculoskeletal effects of balaglitazone and pioglitazone in diet-induced obese rats.
Topics: Adipogenesis; Animals; Biomarkers; Blood Glucose; Body Weight; Bone and Bones; Bone Resorption; Diet; Glucose Tolerance Test; Hypoglycemic Agents; Lipid Metabolism; Magnetic Resonance Imaging; Male; Muscles; Obesity; Osteogenesis; Pioglitazone; PPAR alpha; Quinazolines; Rats; Thiazolidinediones; Water | 2009 |
Rutecarpine ameliorates bodyweight gain through the inhibition of orexigenic neuropeptides NPY and AgRP in mice.
Topics: Agouti-Related Protein; Animals; Cell Line; Down-Regulation; Eating; Hypothalamus; Indole Alkaloids; Mice; Mice, Inbred C57BL; Neurons; Neuropeptide Y; Obesity; Promoter Regions, Genetic; Quinazolines; Weight Gain | 2009 |
Inhibitory effect of evodiamine alone and in combination with rosiglitazone on in vitro adipocyte differentiation and in vivo obesity related to diabetes.
Topics: Adipocytes; Adiponectin; Adipose Tissue; Animals; Blood Glucose; Cell Differentiation; Cell Line; Dietary Fats; Drug Therapy, Combination; Hypoglycemic Agents; Insulin; Liver; Mice; Mice, Inbred C57BL; Obesity; Plant Extracts; Quinazolines; Rosiglitazone; Thiazolidinediones; Weight Gain | 2010 |
Suppression of lipin-1 expression increases monocyte chemoattractant protein-1 expression in 3T3-L1 adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Chemokine CCL2; Chemotaxis; Gene Expression; Insulin Resistance; Mice; NF-kappa B; Nuclear Proteins; Obesity; Phosphatidate Phosphatase; Protein Biosynthesis; Quinazolines; RNA, Messenger; RNA, Small Interfering; Salicylates | 2011 |
Evaluation of body fat composition after linagliptin treatment in a rat model of diet-induced obesity: a magnetic resonance spectroscopy study in comparison with sibutramine.
Topics: Adiposity; Animals; Appetite Depressants; Body Composition; Cyclobutanes; Disease Models, Animal; Female; Linagliptin; Obesity; Purines; Quinazolines; Rats; Rats, Wistar | 2012 |
Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity.
Topics: Adipose Tissue; Animals; Diet; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Fatty Liver; Female; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Insulin; Insulin Resistance; Linagliptin; Liver; Mice; Mice, Inbred C57BL; Obesity; Purines; Quinazolines | 2012 |
Effects of the DPP-4 inhibitor, linagliptin, in diet-induced obese rats: a comparison in naive and exenatide-treated animals.
Topics: Animals; Diet; Dipeptidyl-Peptidase IV Inhibitors; Female; Linagliptin; Obesity; Purines; Quinazolines; Rats; Rats, Wistar | 2012 |
The DPP-4 inhibitor linagliptin counteracts stroke in the normal and diabetic mouse brain: a comparison with glimepiride.
Topics: Animals; Diabetes Mellitus, Experimental; Dietary Fats; Dipeptidyl-Peptidase IV Inhibitors; Hypoglycemic Agents; Linagliptin; Male; Mice; Obesity; Purines; Quinazolines; Stroke; Sulfonylurea Compounds | 2013 |
Evodiamine improves diet-induced obesity in a uncoupling protein-1-independent manner: involvement of antiadipogenic mechanism and extracellularly regulated kinase/mitogen-activated protein kinase signaling.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Anti-Obesity Agents; Cell Differentiation; Diet, Atherogenic; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Insulin; Ion Channels; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondrial Proteins; Obesity; Plant Extracts; Quinazolines; Signal Transduction; Uncoupling Protein 1 | 2008 |
Dual purinergic synaptic transmission in the human enteric nervous system.
Topics: Aniline Compounds; Calcium; Chloride Channels; Electric Stimulation; Enteric Nervous System; Fluorescent Dyes; Humans; Microscopy, Confocal; Nerve Fibers; Neurons; Obesity; Quinazolines; Receptors, Purinergic; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Submucous Plexus; Synaptic Transmission; Triazoles; Type C Phospholipases; Vasoactive Intestinal Peptide; Xanthenes | 2008 |
[Alström syndrome--a rare disease of diabetic association].
Topics: Adult; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diagnosis, Differential; DNA Mutational Analysis; Humans; Male; Obesity; Optic Atrophy; Quinazolines; Retinitis Pigmentosa; Second Messenger Systems; Syndrome | 1997 |
Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist.
Topics: Adipose Tissue; Animals; Anti-Obesity Agents; Body Temperature; Body Weight; Capsaicin; Cholesterol; Fatty Acids, Nonesterified; Fruit; Japan; Lipid Metabolism; Lipolysis; Liver; Male; Medicine, East Asian Traditional; Mice; Mice, Inbred C3H; Obesity; Phytotherapy; Plant Extracts; Plants, Medicinal; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Drug; Rutaceae; Triglycerides | 2001 |
Insulin insensitivity in nonobese, nondiabetic essential hypertension and its improvement by an alpha 1-blocker (bunazosin).
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Apoproteins; Blood Glucose; Blood Pressure; Catecholamines; Diabetes Mellitus; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Resistance; Lipids; Male; Middle Aged; Obesity; Quinazolines; Sodium | 1992 |
Age-related changes in adrenergic alpha 1, alpha 2, and beta receptors of rat white fat cell membranes: an analysis using [3H]bunazosin as a novel ligand for the alpha 1 adrenoceptor.
Topics: Adipose Tissue; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aging; Animals; Binding Sites; Cell Membrane; Epididymis; Kinetics; Male; Obesity; Propanolamines; Quinazolines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Yohimbine | 1991 |